IFN-α/β signaling is required for polarization of cytokine responses toward a protective type 1 pattern during experimental cryptococcosis

Journal of Immunology

Volumn 181, Issue 1, 2008, Pages 566-573

  Biondo, Carmelo ^a   Midiri, Angelina ^a   Gambuzza, Maria ^a   Gerace, Elisabetta ^a   Falduto, Maria ^a   Galbo, Roberta ^a   Bellantoni, Antonella ^a   Beninati, Concetta ^a   Teti, Giuseppe ^a   Leanderson, Tomas ^b   Mancuso, Giuseppe ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON; BETA INTERFERON RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; ALPHA BETA INTERFERON RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; DENDRITIC CELL; EXPERIMENTAL INFECTION; HISTOPATHOLOGY; IMMUNOREACTIVITY; INFECTION RESISTANCE; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; SURVIVAL RATE;

ANIMALS; CELLS, CULTURED; CRYPTOCOCCOSIS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; INTERFERON-ALPHA; INTERFERON-BETA; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION; SURVIVAL RATE;

EID: 47949086661     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.1.566     Document Type: Article

References (45)

1. Sen, G. C. 2001. Viruses and interferons. Anna. Rev. Microbiol. 55: 255-281.
2. Taniguchi, T., and A. Takaoka. 2001. A weak signal for strong responses: inter-feron-α/β revisited. Nature 2: 378-386.
3. Theofilopoulos, A. N., R. Baccala, B. Beutk-r, and D. H. Kono. 2005. Type I interferons (αβ) in immunity and autoimmunity. Annu. Rev. Immunol. 23: 307-335.
4. Beutler, B. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263.
5. Karaghiosoff, M" R. Steinbom, P: Kovarik, G. Kriegshauser, M. Baccarini, B. Donabauer, U. Reichart, T. Kolbe, C. Bogdan, T. Leanderson, et al. 2003. Central role for type I interferons and Tyk2 in lipopolysaccharide- induced endotoxin shock. Nat. Immunol. 4: 471-477.
6. Weighardt, H., S. Kaiser-Moore, S. Schlautkötter, T. Rossmann-Bloeck, U. Schleicher, C. Bogdan, and B. Holzmann. 2006. Type I IFN modulates host defense and late hyperinflammation in septic peritonitis. J. Immunol. 177: 5623-5630.
7. Auerbuch, V., D. G. Brockstedt, N. Meyer-Morse, M. O'Riordan, and D. A. Portnoy. 2004. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 200: 527-533.
8. Carrero, J. A., B. Calderon, and E. R. Unanue. 2004. Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J. Exp. Med. 200: 535-540.
9. O'Connell, R. M" S. K. Saha, S. A. Vaidya, K. W. Bruhn, G. A. Miranda, B. Zamegar, A. K. Perry, B. O. Nguyen, T. F. Lane, T. Taniguchi, et al. 2004. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J. Exp. Med. 200: 437-445.
10. Mancuso, G., A. Midiri, C. Biondo, C. Beninati, S. Zummo, R. Galbo, F. Tomasello, M. Gambuzza, G. Macrì, A. Rugged, et al. 2007. Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J. Immunol. 178: 3126-3133.
11. Jensen, J., A. Vazquez-Torres, and E. Balish. 1992. Poly(I:C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis. Infect. Immun. 60: 4549-4557.
12. Maheshwari, R. K., R. N. Tandon, A. R. Feuillette, G. Mahouy, G. Badillet, and R. M. Friedman. 1988. Interferon inhibits Aspergillus fumigatus growth in mice: an activity against an extracellular infection. J. Interferon Res. 8: 35-44.
13. Steele, C., L. Marrero, S. Swain, A. G. Harmsen, M. Zheng, G. D. Brown, S. Gordon, J. E. Shellito, and J. K. Kolls. 2003. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 β-glucan receptor. J. Exp. Med. 198: 1677-1688.
14. Rogers, N. C., E. C. Slack, A. D. Edwards, M. A. Nolte, O. Schulz, E. Schweighoffer, D. L. Williams, S. Gordon, V. L. Tybulewicz, G. D. Brown, et al. 2005. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22: 507-517.
15. Vetvicka, V., B. P. Thornton, and G. D. Ross. 1996. Soluble β-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CDllb/CD 18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J. Clin. Invest. 98: 50-61.
16. Saijo, S., N. Fujikado, T. Furuta, S. H. Chung, H. Kotaki, K. Seki, K. Sudo, S. Akira, Y. Adachi, N. Ohno, et al. 2007. Decun-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Invmmol. 8: 39-46.
17. Netea, M. G., N. A. Gow, C. A. Munro, S. Bates, C. Collins, G. Ferwerda, R. P. Hobson, G. Bertram, H. B. Hughes, T. Jansen, et al. 2006. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J. Clin. Invest. 116: 1642-1650.
18. Reese, T. A., H. E. Liang, A. M. Tager, A. D. Luster, N. Van Rooijen, D. Voehringer, and R. M. Locksley. 2007. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 447: 92-96.
19. Herring, A. C., J. Lee, R. A. McDonald, G. B. Toews, and G. B. Huffnagle. 2002. Induction of interleukin-12 and γ interferon requires tumor necrosis factor α for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. Infect. Immun. 70: 2959-2964.
20. Biondo, C., A. Midiri, L. Messina, F. Tomasello, G. Garufi, M. R. Catania, M. Bombaci, C. Beninati, G. Teti, and G. Mancuso. 2005. MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans. Eur. J. Immunol. 35: 870-878.
21. Yauch, L. E., M. K. Mansour, S. Shoham, J. B. Rottman, and S. M. Levitz. 2004. Involvement of CD14, Toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo. Infect. Immun. 72: 5373-5382.
22. Olszewski, M. A., G. B. Huffnagle, R. A. McDonald, D. M. Lindell, B. B. Moore, D. N. Cook, and G. B. Toews. 2000. The role of macrophage inflammatory protein-lα/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. J. Immunol. 165: 6429-6436.
23. Arora, S., Y. Hernandez, J. R. Erb-Downward, R. A. McDonald, G. B. Toews, and G. B. Huffnagle. 2005. Role of IFN-γ in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis. J. Immunol. 174: 6346-6356.
24. Erlandsson, L., R. Blumenthal, M. L. Eloranta, H. Engel, G. Aim, S. Weiss, and T. Leanderson. 1998. Interferon-β is required for interferon-α production in mouse fibroblasts. Curr. Biol. 8: 223-226.
25. Fort, M" J. D. Cheung, J. Li Yen, S. Zurawski, S. Lo, S. Menon, T. Clifford, B. Hume, and R. Lesley. 2001. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15: 985-995.
26. Wolf, A. M" D. Wolf, H. Rumpold, S. Ludwiczek, B. Enrich, G. Gastl, G. Weiss, and H. Tilg. 2005. The kinase inhibitor imatinib mesylate inhibits TNF-(α) production in vitro and prevents TNF-dependent acute hepatic inflammation. Proc. Natl. Acad. Sci. USA 102: 13622-13627.
27. Wheeler, R. D., S. P. Zehntner, L. M. Kelly, L. Bourbonniere, and T. Owens. 2006. Elevated interferon γ expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis. Immunology 118: 527-538.
28. Ain, R., J. S. Tash, and M. J. Soares. 2002. A simple method for the in situ detection of eosinophils. J. Immunol. Methods 260: 273-278.
29. Schneider, T., and A. C. Issekutz. 1996. Quantitation of eosinophil and neutrophil infiltration into rat lung by specific assays for eosinophil peroxidase and myeloperoxidase: application in a Brown Norway rat model of allergic pulmonary inflammation. J. Immunol. Methods 198: 1-14.
30. Mancuso, G., A. Midiri, C. Biondo, C. Beninati, M. Gambuzza, D. Macrì, A. Bellantoni, A. Weinlraub, T. Espevik, and G. Teti. 2005. Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via Tolllike receptor 4. Infect. Immun. 73: 5620-5627.
31. Levitz, S. M., T. S. Harrison, A. Tabuni, and X. Liu. 1997. Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation. J. Clin. Invest. 100: 1640-1646.
32. Roseff, S. A., and S. M. Levitz. 1993. Effect of endothelial cells on phagocyte mediated anticryptococcal activity. Infect. Immun. 61:3818-3824.
33. Chen, G. H., R. A. McDonald, J. C. Wells, G. B. Huffnagle, N. W. Lukacs, and G. B. Toews. 2005. The γ interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans. Infect. Immun. 73: 1788-1796.
34. Perfect, J. R., and A. Casadevall. 2002. Cryptococcosis. Infect. Dis. Clin. North Am. 16: 837-874.
35. Koguchi, Y" and K. Kawakami. 2002. Cryptococcal infection and Th1-Th2 cytokine balance. Int. Rev. Immunol. 21: 423-438.
36. Herring, A. C., N. R. Falkowski, G. H. Chen, R. A. McDonald, G. B. Toews, and G. B. Huffnagle. 2005. Transient neutralization of tumor necrosis factor α can produce a chronic fungal infection in an immunocompetent host: potential role of immature dendritic cells. Infect. Immun. 73: 39-49.
37. Pamer, E. G. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4: 812-823.
38. Lee, S. C., D. W. Dickson, C. F. Brosnan, and A. Casadevall. 1994. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J. Exp. Med. 180: 365-369.
39. Montoya, M., G. Schiavoni, F. Mattei, I. Gresser, F. Belardelli, P. Borrow, and D. F. Tough. 2002. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99: 3263-3271.
40. + T cells. J. Exp. Med. 178: 1655-1663.
41. Zhang, T., K. Kawakami, M. H. Qureshi, H. Okamura, M. Kurimoto, and A. Saito. 1997. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of γ interferon by natural killer cells. Infect. Immun. 65: 3594-3599.
42. Kawakami, K., Y. Koguchi, M. H. Qureshi, A. Miyazato, S. Yara, Y. Kinjo, Y. Iwakura, K. Takeda, S.'Akira, M. Kurimoto, and A. Saito. 2000. IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-γ production by NK cells, J. Immunol. 165: 941-947.
43. Cousens, L. P., R. Peterson, S. Hsu, A. Domcr, J. D. Altman, R. Ahmed, and C. A. Biron. 1999. Two roads diverged: interferon α/β- and interleukin 12-me-diated pathways in promoting T cell interferon γ responses during viral infection. J. Exp. Med. 189: 1315-1328.
44. Shoham, S., C. Huang, J. M Chen, D. T. Golenbock, and S. M. Levitz. 2001. Toll-like receptor 4 mediates intracellular signaling without TNF-α release in response to Cryptococcus neoformans polysaccharide capsule. J. Immunol. 166: 4620-4626.
45. Gantner, B. N., R. M. Simmons, S. J. Canavera, S. Akira, and D. M. Underhill. 2003. Collaborative induction of inflammatory responses by dectin-1 and Tolllike receptor 2. J. Exp. Med. 197: 1107-1117.